DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR WARFARIN SODIUM

« Back to Dashboard

Clinical Trials for Warfarin Sodium

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00203580	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	Canadian Institutes of Health Research (CIHR)	Phase 4	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
NCT00203580	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	Dupont Applied Biosciences	Phase 4	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
NCT00203580	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	LEO Pharma	Phase 4	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
NCT00203580	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	University of Calgary	Phase 4	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
NCT00203658	Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin	Completed	Canadian Institutes of Health Research (CIHR)	Phase 4	The purpose of this study is to assess the long-term out-of-hospital treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus low-molecular-weight heparin followed by warfarin sodium.
NCT00203658	Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin	Completed	Dupont Applied Biosciences	Phase 4	The purpose of this study is to assess the long-term out-of-hospital treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus low-molecular-weight heparin followed by warfarin sodium.
NCT00203658	Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin	Completed	LEO Pharma	Phase 4	The purpose of this study is to assess the long-term out-of-hospital treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus low-molecular-weight heparin followed by warfarin sodium.

Clinical Trial Conditions for Warfarin Sodium

Condition Name

Condition Name for Warfarin Sodium
Intervention	Trials
Thrombosis	5
Venous Thrombosis	4
Hypertension	2
Atrial Fibrillation	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Warfarin Sodium
Intervention	Trials
Thrombosis	8
Venous Thrombosis	6
Thromboembolism	4
Hemostatic Disorders	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Warfarin Sodium

Trials by Country

Trials by Country for Warfarin Sodium
Location	Trials
United States	67
Canada	6
Brazil	4
Italy	3
Netherlands	3

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Warfarin Sodium
Location	Trials
Texas	4
California	3
Maryland	3
Ohio	3
North Carolina	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Warfarin Sodium

Clinical Trial Phase

Clinical Trial Phase for Warfarin Sodium
Clinical Trial Phase	Trials
Phase 4	7
Phase 3	5
Phase 2	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Warfarin Sodium
Clinical Trial Phase	Trials
Completed	10
Terminated	6
Recruiting	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Warfarin Sodium

Sponsor Name

Sponsor Name for Warfarin Sodium
Sponsor	Trials
Yangzhou University	2
LEO Pharma	2
Dupont Applied Biosciences	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Warfarin Sodium
Sponsor	Trials
Other	32
Industry	10
NIH	1

Export unavailable in trial.
Subscribe for complete access.